(BUSINESS WIRE)--Acrongenomics Inc. is a publicly traded company that focuses on investing in and commercializing novel technology platforms. Acrongenomics’ goal is to bring novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-orientated applications. The company has its offices in London, England.
